Patent · US Active

Compound having PD-L1 inhibitory activity, preparation method therefor and use thereof

US11787766B2 · kind B2 · utility

0Cited by

2References

3Claims

0Family size

Assignee

SHANGHAI ENNOVABIO PHARMACEUTICALS CO., LTD. · CN

Inventors

Lei Jiang · Shanghai, CN
Jianwen DENG · Shanghai, CN
Xiaoli LU · Shanghai, CN
Ke Shang · Beijing, CN
Jianyong SHOU · Fremont, US
Bing Wang · San Jose, US
Danyi Wu · Shanghai, CN
Xueli Xu · Plainsboro, US
Yuan Xu · Singapore, SG
Yi Zhang · Tuji, CN
Mingwei Zheng · Shanghai, CN

Key dates

Filing date	Aug 17, 2018
Grant date	Oct 17, 2023
Priority date	—
Expiry date	Sep 22, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a compound for the prevention and treatment of diseases associated with PD-L1, a preparation method therefor and use thereof. Specifically, provided are the compound of formula I, the stereoisomer and the racemate thereof, or pharmaceutically acceptable salts thereof, and also provided is an application thereof in the preparation of a drug for the prevention and treatment of diseases associated with PD-L1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.